Application
Western blot analysis of TRAF6 over-expressed 293 cell line, cotransfected with TRAF6 Validated Chimera RNAi ( Cat # H00007189-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with TRAF6 monoclonal antibody (M02), clone 1B2 (Cat # AT4332a ). GAPDH ( 36.1 kDa ) used as specificity and loading control.Application
Western Blot analysis of TRAF6 expression in transfected 293T cell line by TRAF6 monoclonal antibody (M02), clone 1B2.Lane 1: TRAF6 transfected lysate(59.6 KDa).Lane 2: Non-transfected lysate.| Product Name | TRAF6 Antibody (monoclonal) (M02) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MGC:3310, RNF85TNF receptor-associated factor 6 |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2b |
| Clone Number | 1B2 |
| Host Species | Mouse |
| Tested Applications | WB |
| WB:1:500~1000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | MGC:3310 RNF85TNF receptor-associated factor 6 |
|---|---|
| Molecular Weight(MW) | 59573 Da |
| Tissue Specificity | TRAF6 (AAH31052, 413 a.a. ~ 523 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
| Entrez Gene | 7189 |
|---|
Application
Western blot analysis of TRAF6 over-expressed 293 cell line, cotransfected with TRAF6 Validated Chimera RNAi ( Cat # H00007189-R01V ) (Lane 2) or non-transfected control (Lane 1). Blot probed with TRAF6 monoclonal antibody (M02), clone 1B2 (Cat # AT4332a ). GAPDH ( 36.1 kDa ) used as specificity and loading control.
Application
Western Blot analysis of TRAF6 expression in transfected 293T cell line by TRAF6 monoclonal antibody (M02), clone 1B2.Lane 1: TRAF6 transfected lysate(59.6 KDa).Lane 2: Non-transfected lysate.| Application Notes | WB:1:500~1000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
